Dopamine receptor agonists differ in their actions on cardiac ion channels

European Journal of Pharmacology

Volumn 482, Issue 1-3, 2003, Pages 31-37

  Hurst, Raymond S ^a   Higdon, Nicole R ^a   Lawson, Judy A ^a   Clark, Michael A ^a   Rutherford Root, Karen L ^a   McDonald, William G ^a   Haas, Joseph V ^a   McGrath, James P ^a   Meglasson, Martin D ^a  

^a PFIZER INC   (United States)

Author keywords

Action potential duration; Dopamine receptor agonist; hERG channel; Parkinson's disease

Indexed keywords

ANTIPARKINSON AGENT; APOMORPHINE; DOPAMINE RECEPTOR STIMULATING AGENT; PERGOLIDE; POTASSIUM CHANNEL BLOCKING AGENT; POTASSIUM CHANNEL HERG; ROPINIROLE; SUMANIROLE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HEART MUSCLE POTENTIAL; IC 50; MALE; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PURKINJE FIBER; REPOLARIZATION;

EID: 0345599976     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2003.09.054     Document Type: Article

References (30)

1. Ahnve S., Vallin H. Influence of heart rate and inhibition of autonomic tone on the QT interval. Circulation. 65:1982;435-439.
2. Awerbuch G.I., Sandyk R. Autonomic functions in the early stages of Parkinson's disease. Int. J. Neurosci. 74:1994;9-16.
3. Bexton R.S., Vallin H.O., Camm A.J. Diurnal variation of the QT interval: influence of the autonomic nervous system. Br. Heart J. 55:1986;253-258.
4. Braak H., Braak E. Pathoanatomy of Parkinson's disease. J. Neurol. 247(Suppl. 2):2000;II3-II10.
5. Bril A., Gout B., Bonhomme M., Landais L., Faivre J.F., Linee P., Poyser R.H., Ruffolo R.R. Combined potassium and calcium channel blocking activities as a basis for antiarrhythmic efficacy with low proarrhythmic risk: experimental profile of BRL-32872. J. Pharmacol. Exp. Ther. 276:1996;637-646.
6. Browne K.F., Zipes D.P., Heger J.J., Prystowsky E.N. Influence of the autonomic nervous system on the Q-T interval in man. Am. J. Cardiol. 50:1982;1099-1103.
7. Chaudhuri K.R. Autonomic dysfunction in movement disorders. Curr. Opin. Neurol. 14:2001;505-511.
8. Chouabe C., Drici M.D., Romey G., Barhanin J., Lazdunski M. HERG and KvLQT1/IsK, the cardiac K+ channels involved in long QT syndromes, are targets for calcium channel blockers. Mol. Pharmacol. 54:1998;695-703.
9. Choy A.M., Lang C.C., Roden D.M., Robertson D., Wood A.J., Robertson R.M., Biaggioni I. Abnormalities of the QT interval in primary disorders of autonomic failure. Am. Heart J. 136:1998;664-671.
10. Cranefield P.F., Aronson R.S., Wit A.L. Effect of verapamil on the normal action potential and on a calcium-dependent slow response of canine cardiac Purkinje Fibers. Circ. Res. 34:1974;204-213.
11. Curran M.E., Splawski I., Timothy K.W., Vincent G.M., Green E.D., Keating M.T. A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell. 80:1995;795-803.
12. Gill J.L. Design and Analysis of Experiments in the Animal and Medical Sciences, Volume 2. 1978;Iowa State University Press, Iowa.
13. Kallio M., Haapaniemi T., Turkka J., Suominen K., Tolonen U., Sotaniemi K., Heikkila V.P., Myllyla V. Heart rate variability in patients with untreated Parkinson's disease. Eur. J. Neurol. 7:2000;667-672.
14. Kass R.S., Tsien R.W. Multiple effects of calcium antagonists on plateau currents in cardiac Purkinje fibers. J. Gen. Physiol. 66:1975;169-192.
15. Mathias C.J. Cardiovascular autonomic dysfunction in Parkinsonian patients. Clin. Neurosci. 5:1998;153-166.
16. Milliken G.A., Johnson D.E. Analysis of Messy Data Volume 1: Designed Experiments. 1984;Van Nostrand-Reinhold, New York.
17. Mohammad S., Zhou Z., Gong Q., January C.T. Blockage of the HERG human cardiac K+ channel by the gastrointestinal prokinetic agent cisapride. Am. J. Physiol. 273:1997;H2534-H2538.
18. Oka H., Mochio S., Sato H., Katayama K. Prolongation of QTc interval in patients with Parkinson's disease. Eur. Neurol. 37:1997;186-189.
19. Ørskov L., Jakobsen J., Dupont E., de Fine Olivarius B., Christensen N.J. Autonomic function in Parkinsonian patients relates to duration of disease. Neurology. 37:1987;1173-1178.
20. Piha S.J., Rinne J.O., Rinne U.K., Seppänen A. Autonomic dysfunction in recent onset and advanced Parkinson's disease. Clin. Neurol. Neurosurg. 90:1988;221-226.
21. Quadri R., Comino I., Scarzella L., Cacioli P., Zanone M.M., Pipieri A., Bergamasco B., Chiandussi L. Autonomic nervous function in de novo Parkinsonian patients in basal condition and after acute levodopa administration. Funct. Neurology. 15:2000;81-86.
22. Rampe D., Roy M.L., Dennis A., Brown A.M. A mechanism for the proarrhythmic effects of cisapride (Propulsid): high affinity blockade of the human cardiac potassium channel HERG. FEBS Lett. 417:1997;28-32.
23. Redfern W.S., Carlsson L., Davis A.S., Lynch W.G., MacKenzie I., Palethorpe S., Siegl P.K., Strang I., Sullivan A.T., Wallis R., Camm A.J., Hammond T.G. Relationships between preclinical cardiac electrophysiology, clinical QT interval prolongation and torsade de pointes for a broad range of drugs: evidence for a provisional safety margin in drug development. Cardiovasc. Res. 58:2003;32-45.
24. Sanguinetti M.C., Jiang C., Curran M.E., Keating M.T. A mechanistic link between an inherited and an acquired cardiac arrhythmia: HERG encodes the IKr potassium channel. Cell. 81:1995;299-307.
25. Sherer T.B., Betarbet R., Greenamyre J.T. Pathogenesis of Parkinson's disease. Curr. Opin. Investig. Drugs. 2:2001;657-662.
26. Szili-Török T., Kálmán J., Paprika D., Dibó G., Rózsa Z., Rudas L. Depressed baroreflex sensitivity in patients with Alzheimer's and Parkinson's disease. Neurobiol. Aging. 22:2001;435-438.
27. van Haarst A.D., van't Klooster G.A., van Gerven J.M., Schoemaker R.C., van Oene J.C., Burggraaf J., Coene M.C., Cohen A.F. The influence of cisapride and clarithromycin on QT intervals in healthy volunteers. Clin. Pharmacol. Ther. 64:1998;542-546.
28. Yang T., Snyders D., Roden D.M. Drug block of IKr: model systems and relevance to human arrhythmias. J. Cardiovasc. Pharmacol. 38:2001;737-744.
29. Zhang S., Sawanobori T., Hirano Y., Hiraoka M. Multiple modulations of action potential duration by different calcium channel blocking agents in guinea pig ventricular myocytes. J. Cardiovasc. Pharmacol. 30:1997;489-496.
30. Zhou Z., Vorperian V.R., Gong Q., Zhang S., January C.T. Block of HERG potassium channels by the antihistamine astemizole and its metabolites desmethylastemizole and norastemizole. J. Cardiovasc. Electrophysiol. 10:1999;836-843.